Anti‐COVID‐19 measurements for hidradenitis suppurativa patients

The reported incidence of COVID‐19 among cohorts of patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may further modify disease severity as some biological modifiers, such as anakinra, are also proposed for the management of COVID‐19 patients pote...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Dermatol
Main Authors: Giamarellos‐Bourboulis, Evangelos J., Bettoli, Vincenzo, Jemec, Gregor B. E., del Marmol, Veronique, Marzano, Angelo V., Prens, Errol P., Tzellos, Thrasyvoulos, Zouboulis, Christos C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
10th European Hidradenitis Suppurativa (EHSF) e.V. Conference
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207032/
https://ncbi.nlm.nih.gov/pubmed/34085330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/exd.14339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados